Anne Joutel (born 1965) is a French neurologist and neuroscientist who is Research Director at the Institute of Psychiatry and Neurosciences of Paris.
The Institute consists of a multi-disciplinary team of over 150 neuroscientists and others working on neurodevelopment and psychiatry; the neurovascular system; multiscale imaging; translational neuroscience, and molecular and cellular mechanisms in the ageing brain.
[1][2][3] Joutel studies the pathogenic mechanisms of small vessel diseases (SVD) of the brain.
In partnership with the pharmaceutical company Lundbeck, she established the proof of concept of the therapeutic efficacy of passive immunization against Notch 3 in a pre-clinical CADASIL model.
She now collaborates with Mark T. Nelson of the University of Vermont, USA as part of a Transatlantic Network of Excellence on the pathogenesis of cerebral SVD, funded by the Leducq Foundation.